Esra Acıman Demirel
Esra Acıman Demirel has a total of 117 co-authors. Here are the top co-authors by number of shared publications:
- Hüsyin Tuğrul ATASOY
Zonguldak Bulent Ecevit University, Faculty of Medicine, Department of Neurology, Zonguldak, Turkey
5 shared publications - Mustafa Açikgöz
Department of Neurology , Zonguldak Bülent Ecevi̇t University , Zonguldak , Türkiye
5 shared publications - Ulufer Celebi
Zonguldak Bulent Ecevit University, Faculty of Medicine, Department of Neurology, Zonguldak, Turkey
5 shared publications - Bilge Piri Cinar
Department of Neurology, Samsun University School of Medicine, Samsun, Turkey
4 shared publications - Aynur Özge
Department of Neurology, Mersin University School of Medicine, Mersin, Turkey
2 shared publications - Burcu Karpuz Seren
Tekirdağ Namık Kemal University, School of Medicine, Department of Neurology, Tekirdağ, Türkiye
2 shared publications
Latest Publications
- 6 November 2026
- Published by Taylor & Francis
- p. 225-231
Alzheimer's Disease with Chronic Migraine and Insomnia
- 6 November 2026
- Published by Taylor & Francis
- p. 225-231
Alzheimer's Disease with Chronic Migraine and Insomnia
- 3 January 2026
- Published by Springer Nature
- p. 333-339
Headache Attributed to a Substance or Its Withdrawal: Carbon Monoxide (CO)-Induced Headache
- 3 January 2026
- Published by Springer Nature
- p. 333-339
Headache Attributed to a Substance or Its Withdrawal: Carbon Monoxide (CO)-Induced Headache
- Open Access
- 31 October 2025
- Published by Springer Nature in BMC Neurology
- Vol. 25 (1) , 1-11
Fear of Movement: Validity and Reliability Study of the Turkish Version of the Tampa Scale of Kinesiophobia for Headache in Patients with Migraine
While triggering by physical activity is a criterion for the diagnosis of migraine, evaluations regarding fear of movement related to physical activity are lacking in the literature. This study aimed to investigate the validity and reliability of the Turkish version of the Tampa Scale of Kinesiophobia, adapted to headache (TSK-H), in patients with episodic migraine (EM) and chronic migraine (CM). This questionnaire is a newly developed version adapted for headache, based on but different from the original TSK used in low back pain, and has not been previously validated in Turkish for headache. Patients between the ages of 18–70 were included in the study. Demographic-clinical information was obtained after expert committee evaluation and cross-cultural adaptation of the questionnaire. Numerical Pain Rating Scale (NPRS), Migraine Disability Assessment (MIDAS), Headache Impact Test-6 (HIT-6), Hospital Anxiety and Depression Scale (HADS) and TSK-H were evaluated for structural validity. Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) were performed. Intraclass Correlation Coefficient (ICC) and Cronbach’s α values were analyzed for reliability. A total of 329 patients (n = 148 EM, n = 181 CM) with a mean age of 37.2 ± 10.6 years for EM and 39.8 ± 13.1 years for CM were included in the study. Headache intensity on NPRS was 6.89 ± 1.86 for EM and 7.56 ± 2.10 for CM. Item-total correlations ranged from − 0.030 to 0.758. Cronbach’s α was 0.925. TSK-H had good test-retest reliability (ICC = 0.866, n = 151) and high internal consistency (Cronbach’s α = 0.928). TSK-H was associated with NPRS, MIDAS, HIT-6 and HADS (p < 0.000 for each one). EFA identified a four-factor structure explaining 58.64% of the variance. CFA remained within acceptable limits. The Turkish version of the 23-item TSK-H is a valid and reliable tool for assessing kinesiophobia in patients with migraine and is significantly associated with physical, functional and psychosocial factors.
- 31 October 2025
- Published by Springer Nature in BMC Neurology
- Vol. 25 (1) , 1-11
Open AccessFear of Movement: Validity and Reliability Study of the Turkish Version of the Tampa Scale of Kinesiophobia for Headache in Patients with Migraine
While triggering by physical activity is a criterion for the diagnosis of migraine, evaluations regarding fear of movement related to physical activity are lacking in the literature. This study aimed to investigate the validity and reliability of the Turkish version of the Tampa Scale of Kinesiophobia, adapted to headache (TSK-H), in patients with episodic migraine (EM) and chronic migraine (CM). This questionnaire is a newly developed version adapted for headache, based on but different from the original TSK used in low back pain, and has not been previously validated in Turkish for headache. Patients between the ages of 18–70 were included in the study. Demographic-clinical information was obtained after expert committee evaluation and cross-cultural adaptation of the questionnaire. Numerical Pain Rating Scale (NPRS), Migraine Disability Assessment (MIDAS), Headache Impact Test-6 (HIT-6), Hospital Anxiety and Depression Scale (HADS) and TSK-H were evaluated for structural validity. Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) were performed. Intraclass Correlation Coefficient (ICC) and Cronbach’s α values were analyzed for reliability. A total of 329 patients (n = 148 EM, n = 181 CM) with a mean age of 37.2 ± 10.6 years for EM and 39.8 ± 13.1 years for CM were included in the study. Headache intensity on NPRS was 6.89 ± 1.86 for EM and 7.56 ± 2.10 for CM. Item-total correlations ranged from − 0.030 to 0.758. Cronbach’s α was 0.925. TSK-H had good test-retest reliability (ICC = 0.866, n = 151) and high internal consistency (Cronbach’s α = 0.928). TSK-H was associated with NPRS, MIDAS, HIT-6 and HADS (p < 0.000 for each one). EFA identified a four-factor structure explaining 58.64% of the variance. CFA remained within acceptable limits. The Turkish version of the 23-item TSK-H is a valid and reliable tool for assessing kinesiophobia in patients with migraine and is significantly associated with physical, functional and psychosocial factors.
- Open Access
- 3 July 2024
- Published by The European Research Journal in The European Research Journal
- Vol. 10 (4) , 405-413
Distribution of neuropsychiatric profiles and comorbid diseases in dementia subtypes
Objectives: Alzheimer’s disease (AH) is the most prevalent cause of dementia, followed closely by vascular dementia. Mixed vascular-Alzheimer’s dementia (MVAD) is more evident in individuals aged 80 and above. Frontotemporal dementia (FTD) is the second most common cause of early-onset dementia after AH. Vascular risk factors play important role in the pathogenesis of dementia syndromes. Behavioral and psychological symptoms represent a significant portion of the non-cognitive manifestations in dementia patients. This study aimed to evaluate the distribution of chronic diseases, behavioral disorders, psychiatric findings, and medication use in patients followed with different dementia diagnoses. Methods: Prevalance of chronic diseases, behavioral disorders, psychiatric findings as well as the usage of antidepressant and antipsychotic medications among patients followed up in dementia outpatient clinics with the diagnosis of AD, mild cognitive impairment (MCI), vascular dementia (VaD), FTD, and MVAD were investigated. Neuropsychiatric inventory (NPI) was applied to the patients. Results: Four hundred and fifty-five patients were accepted in the study. The patients were distributed as follows: AD (n=303, female/male: 187/115, age = 78±8 years), MCI (n=53, female/male: 31/22, age = 69±10 years), VaD (n=31, female/male: 18/13, age = 68±9 years), FTD (n=32, female/male: 17/15, age = 68±9 years), and MVAD (n=36, female/male: 16/20, age = 76±10 years). Both AD and MVAD groups were significantly older than the other groups (F = 23.2, P<0.0001). The ratio of comorbid chronic diseases was 80% in the AD group, 72% in the MCI group, 91% in the VaD group, 59% in the FTD group, and 93% in the MVAD group. In the whole group, antipsychotic drug use was 27.5% and antidepressant drug use was 28.9%. The mean NPI score was 32.9±28 in antipsychotic users and 16±19 in non-users (P<0.0001). The mean NPI of antidepressant users was 17.6±19 and 21.9±25 (P=0.055) in non-users. Conclusion: There is a comorbid chronic disease burden in all dementia subtypes, although at varying intensities, and as the chronic disease burden increases, behavioral disorders and psychotic findings increase, and accordingly, the use of antipsychotics also increases.
- 3 July 2024
- Published by The European Research Journal in The European Research Journal
- Vol. 10 (4) , 405-413
Open AccessDistribution of neuropsychiatric profiles and comorbid diseases in dementia subtypes
Objectives: Alzheimer’s disease (AH) is the most prevalent cause of dementia, followed closely by vascular dementia. Mixed vascular-Alzheimer’s dementia (MVAD) is more evident in individuals aged 80 and above. Frontotemporal dementia (FTD) is the second most common cause of early-onset dementia after AH. Vascular risk factors play important role in the pathogenesis of dementia syndromes. Behavioral and psychological symptoms represent a significant portion of the non-cognitive manifestations in dementia patients. This study aimed to evaluate the distribution of chronic diseases, behavioral disorders, psychiatric findings, and medication use in patients followed with different dementia diagnoses. Methods: Prevalance of chronic diseases, behavioral disorders, psychiatric findings as well as the usage of antidepressant and antipsychotic medications among patients followed up in dementia outpatient clinics with the diagnosis of AD, mild cognitive impairment (MCI), vascular dementia (VaD), FTD, and MVAD were investigated. Neuropsychiatric inventory (NPI) was applied to the patients. Results: Four hundred and fifty-five patients were accepted in the study. The patients were distributed as follows: AD (n=303, female/male: 187/115, age = 78±8 years), MCI (n=53, female/male: 31/22, age = 69±10 years), VaD (n=31, female/male: 18/13, age = 68±9 years), FTD (n=32, female/male: 17/15, age = 68±9 years), and MVAD (n=36, female/male: 16/20, age = 76±10 years). Both AD and MVAD groups were significantly older than the other groups (F = 23.2, P<0.0001). The ratio of comorbid chronic diseases was 80% in the AD group, 72% in the MCI group, 91% in the VaD group, 59% in the FTD group, and 93% in the MVAD group. In the whole group, antipsychotic drug use was 27.5% and antidepressant drug use was 28.9%. The mean NPI score was 32.9±28 in antipsychotic users and 16±19 in non-users (P<0.0001). The mean NPI of antidepressant users was 17.6±19 and 21.9±25 (P=0.055) in non-users. Conclusion: There is a comorbid chronic disease burden in all dementia subtypes, although at varying intensities, and as the chronic disease burden increases, behavioral disorders and psychotic findings increase, and accordingly, the use of antipsychotics also increases.
- 28 June 2024
- Published by Marmara University in Clinical and Experimental Health Sciences
- Vol. 14 (2) , 525-530
An Evaluation of The Relationship Between Falls, Osteoporosis And The Parkinson’s Disease Rating Scale In Patients With Parkinson’s Disease
Objective: The purpose of this study is to examine conditions such as balance disorder, risk of falling, fear of falling, vitamin D deficiency and osteoporosis in people with Parkinson's Disease (PD), and their association with the Movement Disorders Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) sub-components, which are used to follow-up these patients. Methods: The study comprised 38 patients who were followed up for idiopathic PD. All the patients’ demographic data, falls efficacy scale, number of falls within the last year, history of fractures, Berg Balance Scale, the MDS-UPDRS sub-components, vitamin D levels, and bone mineral densitometry values were recorded. Results: There was a positive correlation between the MDS-UPDRS Part I and the number of falls and the history of fractures, and a positive correlation with the Hoehn and Yahr scale, and the MDS-UPDRS Part II, III and total and the Berg Balance Scale, the Falls Efficacy Scale, and the number of falls. Our study found that the bone mineral densitometry values for the femoral neck were lower in women than in men, and there was a positive correlation between the bone mineral densitometry values for the femoral neck and the body mass index. A positive correlation was established between levodopa use and the falls efficacy scale. Conclusion: Falls, imbalance, osteoporosis are life-threatening conditions in patients with PD. This study established that the MDS-UPDRS, used to follow-up patients, was associated with these conditions. It is believed that this assessment method may also give an idea about these conditions in PD patients who are followed up using this scale.
- 28 June 2024
- Published by Marmara University in Clinical and Experimental Health Sciences
- Vol. 14 (2) , 525-530
An Evaluation of The Relationship Between Falls, Osteoporosis And The Parkinson’s Disease Rating Scale In Patients With Parkinson’s Disease
Objective: The purpose of this study is to examine conditions such as balance disorder, risk of falling, fear of falling, vitamin D deficiency and osteoporosis in people with Parkinson's Disease (PD), and their association with the Movement Disorders Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) sub-components, which are used to follow-up these patients. Methods: The study comprised 38 patients who were followed up for idiopathic PD. All the patients’ demographic data, falls efficacy scale, number of falls within the last year, history of fractures, Berg Balance Scale, the MDS-UPDRS sub-components, vitamin D levels, and bone mineral densitometry values were recorded. Results: There was a positive correlation between the MDS-UPDRS Part I and the number of falls and the history of fractures, and a positive correlation with the Hoehn and Yahr scale, and the MDS-UPDRS Part II, III and total and the Berg Balance Scale, the Falls Efficacy Scale, and the number of falls. Our study found that the bone mineral densitometry values for the femoral neck were lower in women than in men, and there was a positive correlation between the bone mineral densitometry values for the femoral neck and the body mass index. A positive correlation was established between levodopa use and the falls efficacy scale. Conclusion: Falls, imbalance, osteoporosis are life-threatening conditions in patients with PD. This study established that the MDS-UPDRS, used to follow-up patients, was associated with these conditions. It is believed that this assessment method may also give an idea about these conditions in PD patients who are followed up using this scale.
- 15 December 2023
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 10 (4) , 307-314
A Pilot Study on Sex Hormones and Cognition in Men with Multiple Sclerosis
- 15 December 2023
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 10 (4) , 307-314
A Pilot Study on Sex Hormones and Cognition in Men with Multiple Sclerosis
- Open Access
- 4 September 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (17) , 5754
One Patient, Three Providers: A Multidisciplinary Approach to Managing Common Neuropsychiatric Cases
Background: Neuropsychiatric cases require a multidisciplinary approach for effective management. This paper presented case-based discussions on migraine, dementia, epilepsy, mood disorders, neuralgia, and psychosis from the perspectives of a family physician, neurologist, and psychiatrist. The goal was to highlight the importance of collaboration between healthcare providers in managing these complex cases. Methods: The paper was based on the proceedings of the Mediterranean Neuropsychiatry Symposium, where experts from family medicine, neurology, and psychiatry came together for comprehensive case-based discussions. The CARE framework (Case Report, Appraisal, Research, and Education) was developed to guide reporting and evaluation of case reports in clinical practice. Results: Six cases were presented and discussed, highlighting the importance of a multidisciplinary approach in managing neuropsychiatric cases. The cases included chronic migraine with medication overuse, memory dysfunction with language and behavioral problems, refractory epileptic seizures with subjective sensory symptoms, bipolar affective disorder with normal pressure hydrocephalus, postherpetic neuralgia in a case with bipolar affective disorder, and psychosis with recurrent attacks with the abuse of several substances. Conclusion: A biopsychosocial multidisciplinary approach is essential for managing neuropsychiatric cases effectively on behalf of the patients and public health of the country. The CARE framework can guide the reporting and evaluation of case reports in clinical practice, ensuring that patients receive comprehensive and effective care. Healthcare providers should collaborate to provide the best possible care for patients with complex and multifaceted needs.
- 4 September 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (17) , 5754
Open AccessOne Patient, Three Providers: A Multidisciplinary Approach to Managing Common Neuropsychiatric Cases
Background: Neuropsychiatric cases require a multidisciplinary approach for effective management. This paper presented case-based discussions on migraine, dementia, epilepsy, mood disorders, neuralgia, and psychosis from the perspectives of a family physician, neurologist, and psychiatrist. The goal was to highlight the importance of collaboration between healthcare providers in managing these complex cases. Methods: The paper was based on the proceedings of the Mediterranean Neuropsychiatry Symposium, where experts from family medicine, neurology, and psychiatry came together for comprehensive case-based discussions. The CARE framework (Case Report, Appraisal, Research, and Education) was developed to guide reporting and evaluation of case reports in clinical practice. Results: Six cases were presented and discussed, highlighting the importance of a multidisciplinary approach in managing neuropsychiatric cases. The cases included chronic migraine with medication overuse, memory dysfunction with language and behavioral problems, refractory epileptic seizures with subjective sensory symptoms, bipolar affective disorder with normal pressure hydrocephalus, postherpetic neuralgia in a case with bipolar affective disorder, and psychosis with recurrent attacks with the abuse of several substances. Conclusion: A biopsychosocial multidisciplinary approach is essential for managing neuropsychiatric cases effectively on behalf of the patients and public health of the country. The CARE framework can guide the reporting and evaluation of case reports in clinical practice, ensuring that patients receive comprehensive and effective care. Healthcare providers should collaborate to provide the best possible care for patients with complex and multifaceted needs.
- 5 April 2023
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 141 (5) , 1011-1013
Laparoscopic Diagnosis and Treatment of an Isolated Cervical Diverticulum
BACKGROUND: Congenital müllerian anomalies are found in 8.0% of women with infertility and up to 5.5% of women in a general population. Cervical diverticulum is a type of cervical malformation that can be congenital or acquired, with only select cases documented in the literature. Cervical diverticulum can be asymptomatic or present with abnormal uterine bleeding, pelvic pain, or infertility. Previously described management options are largely limited to observation or exploratory laparotomy. CASE: A 35-year-old woman, gravida 2 para 2, presented with persistent menorrhagia, pelvic pain, and abdominal bloating and was found to have an 8-cm right adnexal mass on pelvic ultrasonography. Magnetic resonance imaging showed a hemorrhagic cervical mass communicating with the uterine cavity. The mass was resected laparoscopically, and pathology revealed fibromuscular tissue with endocervical epithelium consistent with a cervical diverticulum. CONCLUSION: Isolated cervical diverticula are rare but should be considered in the differential diagnosis of adnexal masses. Laparoscopic surgery is a safe, minimally invasive approach for evaluation and repair of cervical diverticula.
- 5 April 2023
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 141 (5) , 1011-1013
Laparoscopic Diagnosis and Treatment of an Isolated Cervical Diverticulum
BACKGROUND: Congenital müllerian anomalies are found in 8.0% of women with infertility and up to 5.5% of women in a general population. Cervical diverticulum is a type of cervical malformation that can be congenital or acquired, with only select cases documented in the literature. Cervical diverticulum can be asymptomatic or present with abnormal uterine bleeding, pelvic pain, or infertility. Previously described management options are largely limited to observation or exploratory laparotomy. CASE: A 35-year-old woman, gravida 2 para 2, presented with persistent menorrhagia, pelvic pain, and abdominal bloating and was found to have an 8-cm right adnexal mass on pelvic ultrasonography. Magnetic resonance imaging showed a hemorrhagic cervical mass communicating with the uterine cavity. The mass was resected laparoscopically, and pathology revealed fibromuscular tissue with endocervical epithelium consistent with a cervical diverticulum. CONCLUSION: Isolated cervical diverticula are rare but should be considered in the differential diagnosis of adnexal masses. Laparoscopic surgery is a safe, minimally invasive approach for evaluation and repair of cervical diverticula.
- 11 March 2023
- Published by Springer Nature in Neurological Sciences
- Vol. 44 (8) , 2871-2881
IVIg-induced headache: prospective study of a large cohort with neurological disorders
Background Intravenous immune globulin (IVIg) is frequently used in some neurological diseases and is also the first-line therapy in Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy. We aimed to evaluate the frequency and characteristics of headaches, which is one of the most common side effects of IVIg treatment. Methods Patients who received IVIg treatment for neurological diseases were prospectively enrolled in 23 centers. Firstly, the characteristics of patients with and without IVIg-induced headaches were analyzed statistically. Then, patients with IVIg-induced headaches were classified into three subgroups determined by their history: no primary headache, tension-type headache (TTH), and migraine. Results A total of 464 patients (214 women) and 1548 IVIg infusions were enrolled between January and August 2022. The frequency of IVIg-related headaches was 27.37% (127/464). A binary logistic regression analysis performed with significant clinical features disclosed that female sex and fatigue as a side effect were statistically more common in the IVIg-induced headache group. IVIg-related headache duration was long and affected daily living activities more in patients with migraine compared to no primary headache and TTH groups (p = 0.01, respectively). Conclusion Headache is more likely to occur in female patients receiving IVIg and those who develop fatigue as a side effect during the infusion. Clinicians’ awareness of IVIg-related headache characteristics, especially in patients with migraine, may increase treatment compliance.
- 11 March 2023
- Published by Springer Nature in Neurological Sciences
- Vol. 44 (8) , 2871-2881
IVIg-induced headache: prospective study of a large cohort with neurological disorders
Background Intravenous immune globulin (IVIg) is frequently used in some neurological diseases and is also the first-line therapy in Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy. We aimed to evaluate the frequency and characteristics of headaches, which is one of the most common side effects of IVIg treatment. Methods Patients who received IVIg treatment for neurological diseases were prospectively enrolled in 23 centers. Firstly, the characteristics of patients with and without IVIg-induced headaches were analyzed statistically. Then, patients with IVIg-induced headaches were classified into three subgroups determined by their history: no primary headache, tension-type headache (TTH), and migraine. Results A total of 464 patients (214 women) and 1548 IVIg infusions were enrolled between January and August 2022. The frequency of IVIg-related headaches was 27.37% (127/464). A binary logistic regression analysis performed with significant clinical features disclosed that female sex and fatigue as a side effect were statistically more common in the IVIg-induced headache group. IVIg-related headache duration was long and affected daily living activities more in patients with migraine compared to no primary headache and TTH groups (p = 0.01, respectively). Conclusion Headache is more likely to occur in female patients receiving IVIg and those who develop fatigue as a side effect during the infusion. Clinicians’ awareness of IVIg-related headache characteristics, especially in patients with migraine, may increase treatment compliance.
- Open Access
- 1 September 2022
- Published by ASEAN Neurological Association in Neurology Asia
- Vol. 27 (3) , 725-735
The impact of the COVID-19 pandemic on patients with tension-type headache: A multicenter survey
- 1 September 2022
- Published by ASEAN Neurological Association in Neurology Asia
- Vol. 27 (3) , 725-735
Open AccessThe impact of the COVID-19 pandemic on patients with tension-type headache: A multicenter survey